IMBiotechnologies’ core product, Ekobi Embolization Microspheres, is a biodegradable embolic agent that is detectable by ultrasound and approved in the U.S. to treat inoperable hypervascularized tumors, according to a June 12 press release.
Medicus was founded by a group of physicians and partners with vascular ASCs and office-based labs.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
